The medicinal cannabis market is experiencing a meteoric rise globally, witnessing rapid expansion as more nations worldwide move towards legalization and regulation of cannabis for health-related purposes. In the recent past, there has been a marked increase in the awareness and acceptance of potential therapeutic benefits of cannabis, which significantly contributes to this escalating growth. The demand from patients and healthcare professionals for various cannabis-based therapeutic products is also on the rise, further augmenting the market expansion. In the year 2022, the estimated value of the global medicinal cannabis market was a staggering US$24 billion. This impressive figure is expected to more than double by 2028, with projections estimating the value to reach a sizable US$57 billion. This robust growth trend is primarily driven by a combination of factors. These include an increase in the legalization and regulation efforts of cannabis across different countries, a growing awareness of the potential therapeutic benefits that cannabis offers, and an increasing demand from both patients and healthcare professionals who are recognizing the potential of cannabis in managing various health conditions. North America, particularly the United States, holds the title for the largest medicinal cannabis market in the world. The US market alone, with its progressive laws and increasing acceptance of medicinal cannabis, is valued at over US$18 billion. This represents a significant chunk of the global market, reflecting the nation’s pioneering role in embracing the potential of medicinal cannabis. However, the growth of the medicinal cannabis market is not confined to North America alone. Other major markets are also emerging on the world stage. Europe, with its advanced healthcare systems and increasingly liberal views on cannabis, has also become a significant player in the global medicinal cannabis market. Simultaneously, Latin America, due to its favorable climatic conditions for cannabis cultivation and evolving legal frameworks, is becoming a potential market for medicinal cannabis. Australia, too, is making notable strides in the medicinal cannabis market. With the Australian government increasingly recognizing the potential benefits of medicinal cannabis and making efforts to regulate its use, the country is poised to become a key player in the global medicinal cannabis market. In conclusion, the medicinal cannabis market is thriving across the globe due to increasing legalization and regulation, growing awareness of the potential therapeutic benefits, and rising demand from patients and healthcare professionals. This trend is particularly pronounced in North America, but other regions like Europe, Latin America, and Australia are also witnessing substantial growth. As the understanding and acceptance of the potential therapeutic benefits of cannabis continue to increase, it is expected that the global medicinal cannabis market will continue to grow and evolve.

North America

The United States holds the position of the largest medicinal cannabis market globally, leading the way in the cannabis industry. This is due to the legalization of medicinal cannabis in 38 states and the District of Columbia, which has sparked a surge in the cannabis sector, further propelling the US to the forefront of the industry. The acceptance of medicinal cannabis in these regions has been rooted in the growing recognition of the potential health benefits of this plant, including its use in the treatment of chronic pain, multiple sclerosis, and certain mental health conditions. This evolving perception of cannabis, along with its legalization, has opened up a lucrative market that is expected to reach a staggering US$30 billion by the year 2028. In addition to the United States, other major markets in North America include Canada and Mexico, both of which are significant players in the cannabis market. Canada has been progressive in its stance toward cannabis, legalizing recreational use in 2018, a move that not only broke the stigma associated with the plant but also added a new dimension to its market. With the rise of cannabis-infused products, edibles, and concentrates, Canada’s medicinal cannabis market is projected to reach an impressive US$5 billion by 2028. On the other hand, Mexico, our southern neighbor, is also showing signs of opening up to the potential that cannabis holds. Mexico is anticipated to legalize medicinal cannabis by 2024, further expanding the North American cannabis market. Although Mexico’s current market is relatively small, the potential for growth is immense. With its forthcoming legalization, Mexico’s cannabis market is projected to reach US$2 billion by 2028, a substantial increase that will drive the overall cannabis market in North America. In conclusion, the North American region, led by the United States, is witnessing a paradigm shift in its approach towards cannabis. The transformation from a stigmatized substance to a recognized medicinal aid has propelled the growth of the cannabis market. With continued research and policy changes, the industry’s future looks bright, with the market projected to reach new heights in the coming years. This immense growth and the inclusion of additional markets like Mexico only emphasizes the potential of the cannabis industry in North America, which will undoubtedly have a significant impact on the global cannabis industry.

Europe

Europe, known for its rich history, diverse cultures, and advanced economies, has risen to prominence as the second-largest medicinal cannabis market globally. This soaring industry is being fueled by a potent cocktail of factors, including growing acceptance of cannabis for medicinal purposes, increased legalization and regulation, and an escalating demand from both the patient and healthcare segments. Germany, famed for its precision engineering and industrial might, leads the European pack in this burgeoning market. With a market value surpassing US$2 billion, it stands tall as Europe’s largest medicinal cannabis market. The medical community in Germany has seen a substantial shift in its perception of cannabis, previously associated with stigma and controversy. This change in mindset has played a pivotal role in the growth of Germany’s medicinal cannabis market. Moreover, the stringent yet efficient regulatory framework in place has ensured a streamlined and controlled distribution of medicinal cannabis, further propelling the market’s expansion. The United Kingdom, Italy, and France also prominently feature on the map of major medicinal cannabis markets in Europe. Each of these countries has their unique backdrop of socio-cultural and legal factors shaping their respective markets. The UK, known for its stiff upper lip, has gradually softened its stance towards medicinal cannabis use, largely driven by the rising awareness of its therapeutic benefits. In Italy, the home of la dolce vita, the government’s proactive stance in legalizing medicinal cannabis has spurred growth in the market. France, the land of liberty, equality, and fraternity, has begun to recognize the benefits of medicinal cannabis, catalyzing a shift in its healthcare and legal landscape. Looking towards the future, the European medicinal cannabis market is poised for explosive growth. It is forecasted to reach an astounding US$10 billion by 2028. This projected growth trajectory points to an increasingly liberal legal environment and the continued destigmatization of cannabis use in the medical community. As European nations continue to grapple with an aging population and the escalating burden of chronic diseases, medicinal cannabis could provide a much-needed remedy. The demand from patients for more holistic and less harmful treatment options, coupled with healthcare professionals’ growing recognition of the therapeutic benefits of cannabis, will likely catalyze this market’s expansion. In summary, the European medicinal cannabis market is on the cusp of a significant boom, fueled by changing perceptions, progressive legislative changes, and increasing demand. As we look towards the future, it is clear that the use of medicinal cannabis in Europe is not a fleeting trend, but rather a transformative shift in the healthcare landscape.

Latin America

Latin America is rapidly emerging as a significant market for medicinal cannabis. This is a region where the potential for cannabis as a therapeutic tool is beginning to be recognized, and it is thus witnessing a surge in the interest and investment in this space. Colombia, Uruguay, and Mexico have been the trailblazers in this regard, having all moved to legalize medicinal cannabis, leading the way for others in the region to follow. Colombia has been at the forefront of this wave, implementing legislation that not only legalizes medicinal cannabis but also regulates its cultivation and distribution. This has set a precedent for other countries in Latin America, showing them that it is possible to establish a legal and regulated medicinal cannabis industry. Uruguay, on the other hand, made history by becoming the first country to fully legalize cannabis, not just for medicinal use but also for recreational purposes. This bold move has put the country on the world map as a leader in cannabis reform. Mexico also joined the ranks by legalizing the use of medicinal cannabis, a significant step for a country that has been deeply affected by the war on drugs. This trend is not confined to these three pioneers. Other countries in the region, including Argentina, Peru, and Chile, are also contemplating legalization. They are closely monitoring the experiences of Colombia, Uruguay, and Mexico, learning from their successes and challenges, and considering how they might apply these lessons to their own contexts. The Latin American medicinal cannabis market is one that is poised for substantial growth. Forecasts suggest that by 2028, it could reach a staggering US$5 billion. This projection reflects the increasing acceptance and regulation of medicinal cannabis, as well as the growing demand from patients and healthcare professionals. The shift toward legalization and regulation is a significant driver behind the projected growth of the industry. As more countries move towards legalization, the market will continue to expand, opening up new opportunities for businesses and investors. Furthermore, the increasing acceptance of medicinal cannabis by the medical community is also fueling this growth. Many healthcare professionals are beginning to recognize the potential benefits of cannabis in treating a range of conditions, from chronic pain to epilepsy to mental health disorders. Beyond this, the demand from patients for alternative treatments is also a significant factor contributing to this growing market. Frustrated with the side effects and limited effectiveness of many conventional treatments, patients are increasingly looking to medicinal cannabis as a potential solution. This is particularly true for those suffering from chronic and debilitating illnesses, for whom conventional treatments often offer little relief. In conclusion, Latin America is set to play a pivotal role in the future of the global medicinal cannabis industry. The journey toward legalization and regulation is well underway, and the potential for growth is immense. As more countries in the region move towards legalization, and as demand from patients and healthcare professionals continue to rise, the future seems bright for the medicinal cannabis market in Latin America.

Australia

In 2016, a significant development took place in Australia’s healthcare sector. The country took the progressive step of legalizing medicinal cannabis, opening up a new avenue of treatment for patients who had previously had limited options. Since then, the market has been on an upward trajectory and is anticipated to reach an astounding US$2 billion mark by the year 2028. This prediction is not just a random guesswork but is based on the current trend and market analysis, and considering the pace at which the medicinal cannabis industry is growing, this estimate seems viable. Several factors are responsible for this rapid growth, and one of the principal ones is the increasing demand from patients and healthcare professionals. With the legalization, patients suffering from chronic conditions, which were previously difficult to manage, have found a new ray of hope. Medicinal cannabis has proven to be effective in managing pain, reducing nausea during cancer treatment, and even helping with conditions like multiple sclerosis and epilepsy. As a result, its demand has grown exponentially. The healthcare professionals, on the other hand, have also recognized the potential benefits of medicinal cannabis—being an alternate form of treatment that could effectively alleviate symptoms of various diseases. With more and more doctors prescribing medicinal cannabis, it has inevitably led to a surge in its demand and consequently, the expansion of the market. Moreover, the government’s role in this growth cannot be understated. The Australian government has been proactive in supporting research and development in this field. They have understood the potential that medicinal cannabis holds and hence, have invested in further research to explore its benefits and increase its usability. Several institutions and companies are being encouraged to undertake research projects, and generous funding and grants are being provided. This patronage from the government has significantly aided in the progression of the medicinal cannabis market. In addition to these, government support has also been evident in the form of favorable policies and regulations. These have facilitated the production, distribution, and usage of medicinal cannabis, making it more accessible to the general public. With easy accessibility and increased awareness about its benefits among the masses, the market has seen a considerable boost. Thus, the legalization of medicinal cannabis in 2016 was just the beginning of a new era in the Australian healthcare sector. The continuous growth in demand, coupled with unwavering government support, has paved the way for a flourishing medicinal cannabis market. This, in turn, has enormous implications for future healthcare policies and practices, with the potential to revolutionize treatment methods, placing Australia at the forefront of innovation in healthcare solutions.

Other markets

Several countries around the world, including Israel, Thailand, and South Africa, are making significant strides in the medicinal cannabis industry. These nations have robust markets for medical cannabis that are anticipated to expand and flourish over the next few years. A plethora of factors are contributing to their growth and evolution, underscoring the dynamic potential of the medicinal cannabis sector globally. Israel, in particular, has long been at the forefront of the global medicinal cannabis industry. Thanks to its advanced medical research facilities and supportive governmental policies towards the use of cannabis for therapeutic purposes, the country has established a thriving market that is poised for further growth. An increasing number of Israeli patients are turning to medicinal cannabis as a viable treatment option, reflecting the growing acceptance of this form of therapy in the nation. Similarly, Thailand has recently experienced a surge in its medicinal cannabis market. The legalization of medical marijuana in 2018 has paved the way for rapid expansion within this segment, with the country now being recognized as a significant player in the global industry. Much of the growth is being driven by the Thai government’s commitment to promoting the use of medicinal cannabis as a way to enhance public health outcomes, bolster domestic agriculture, and stimulate economic growth. South Africa, too, has seen a steady growth in its medicinal cannabis industry. The legalization of private use of cannabis in 2018 was a landmark decision that has since spurred the development of a burgeoning market, catering to an increasing number of patients and healthcare professionals. The South African government is actively working to put solid regulatory frameworks in place to ensure the safe and controlled use of medicinal cannabis, adding further momentum to the industry’s expansion. In summary, the medicinal cannabis market worldwide is experiencing rapid expansion, propelled by a multitude of factors. The increasing legalization and regulation of cannabis, coupled with the growing awareness of its potential therapeutic benefits, is making it a highly sought-after commodity. Furthermore, the demand for medicinal cannabis is escalating, driven by a combination of patient needs and endorsements from healthcare professionals who recognize its potential to alleviate symptoms and improve quality of life. These factors collectively reflect the robust growth trajectory of the medicinal cannabis market, hinting at an even more promising future.

The global medicinal cannabis market is growing rapidly, with a value of US$24 billion in 2022 and expected to reach US$57 billion by 2028¹. This growth is being driven by increasing legalization and regulation, growing awareness of the potential therapeutic benefits of cannabis, and increasing demand from patients and healthcare professionals.

North America is the largest medicinal cannabis market in the world, with the US alone valued at over US$18 billion¹. Other major markets in North America include Canada and Mexico. Canada legalized recreational cannabis in 2018, and the medicinal cannabis market is expected to reach US$5 billion by 2028. Mexico is expected to legalize medicinal cannabis in 2024, and the market is expected to reach US$2 billion by 2028¹.

Europe is the second-largest medicinal cannabis market in the world, with Germany being the largest market in Europe, valued at over US$2 billion. Other major markets include the UK, Italy, and France¹. The European medicinal cannabis market is expected to reach US$10 billion by 2028, driven by increasing legalization and regulation, as well as growing demand from patients and healthcare professionals¹.

Latin America is a growing market for medicinal cannabis, with Colombia, Uruguay, and Mexico having already legalized medicinal cannabis. Other countries in the region are considering legalization. The Latin American medicinal cannabis market is expected to reach US$5 billion by 2028, driven by increasing legalization and regulation, as well as growing demand from patients and healthcare professionals¹.

I hope this information is helpful!

Learn more:

1. marketdataforecast.com2. statista.com3. statista.com4. imarcgroup.com